Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-07-18

Clinical Trial Update: Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy

View source ↗

Summary

This clinical trial update describes a study combining preconditioning chemotherapy with cytokine-induced killer (CIK) cell immunotherapy for non-small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CIK immunotherapy (cytokine-induced killer cells)
  • Preconditioning chemotherapy

Snippet

Sponsor: Jinling Hospital, China | Conditions: Non Small Cell Lung Cancer | Status: UNKNOWN